Phase 3 Lung Cancer Trial, Not Yet Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been confirmed by a lab test to have stage IV non-squamous non-small cell lung cancer (a specific type of advanced lung cancer) that cannot be treated with surgery or radiation.
- Your cancer does not have certain specific genetic changes known as EGFR mutations, or ALK or ROS1 gene rearrangements.
- You have not yet received any systemic treatment (such as chemotherapy or immunotherapy) for your advanced or metastatic lung cancer.
- You have at least one measurable tumor that can be tracked on scans.
- You are in reasonably good general health, able to carry out daily activities with little or no limitation (confirm with trial site).
- Your major organs (such as liver, kidneys, and bone marrow) are functioning well enough as shown by blood tests.
Who may not be able to join:
- You have a mixed or different type of lung cancer, small cell lung cancer, or a related type called neuroendocrine carcinoma.
- You have had another active cancer in the past 5 years or currently have another cancer at the same time.
- Your lung cancer has spread to the brain or spinal cord and is currently causing active symptoms.
- You have known serious lung conditions such as interstitial lung disease, dust-related lung disease, radiation damage to the lungs, or drug-related lung inflammation.
- You have a known active or suspected condition where your immune system attacks your own body (such as lupus or rheumatoid arthritis).
- You have a weakened immune system, are HIV positive, or have active hepatitis B or hepatitis C infection.
- You have previously been treated with pembrolizumab or similar immunotherapy drugs that target PD-1, PD-L1, or CTLA-4.
- You are currently pregnant or breastfeeding.
- The doctor running the trial has a specific reason to believe joining this study could be harmful to you.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Area under the serum concentration-time curve from time 0 to 21 days (AUC0-21d); Area under the serum concentration-time curve within a dosing interval at steady state (AUCss); Best Objective Response Rate (BORR) assessed by Independent Radiology Review Committee (IRRC) based on RECIST v1.1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.